Richard Bucala

Yale Cancer Center — United States

Immunology and Microbiology · Life Sciences

65h-index15.1kcitations210works5.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Macrophage Migration Inhibitory Factor(170), Nuclear Receptors and Signaling(75), Apelin-related biomedical research(20), Galectins and Cancer Biology(12), Pneumocystis jirovecii pneumonia detection and treatment(5)

Publications207 total

Enhanced antibody class switching and T cell responses to a self-amplifying RNA vs mRNA vaccine against SARS-CoV-2 spike protein 4547
The Journal of Immunology·2025Open Access
Increased antibody diversification in mice vaccinated with a self-amplifying RNA versus mRNA directed against SARS-CoV-2 spike protein 9225
The Journal of Immunology·2025Open Access
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer
Oncogenesis·2025· 1 citedOpen Access
Galectin-9 inhibition of the MIF-CD74/CD44 pathway suppresses chronic arthritis
Molecular Therapy·2025Open Access
<scp>MIF</scp> as an oncogenic driver of low‐heterogeneity melanomas
Molecular Oncology·2025Open Access
Decreased T helper 1 cell function underlies recurrent sinopulmonary infections in the 17q12 deletion syndrome
EBioMedicine·2025Open Access
CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells
PLoS Biology·2024· 20 citedOpen Access
763 Therapeutic targeting of the MIF/DDT-CD74 axis in head and neck squamous cell carcinoma (HNSCC) murine models
Regular and Young Investigator Award Abstracts·2024Open Access
571 Dual inhibition of MIF and DDT enhances the efficacy of anti-PD-1 therapy in murine melanoma
Regular and Young Investigator Award Abstracts·2024· 2 citedOpen Access
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma
Oncotarget·2024· 9 citedOpen Access
Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities
International Journal of Molecular Sciences·2024· 12 citedOpen Access
Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus
Arthritis Research & Therapy·2024· 16 citedOpen Access
The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus
Research Square (Research Square)·2023Open Access
A pref-1-controlled non-inflammatory mechanism of insulin resistance
iScience·2023· 7 citedOpen Access
CD74 as a regulator of transcription in normal B cells
Cell Reports·2022· 50 citedOpen Access
Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis
JHEP Reports·2022· 11 citedOpen Access
Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma
Zeitschrift für Gastroenterologie·2021
MP08-05 BLADDER MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) RECEPTORS MEDIATE PAIN
The Journal of Urology·2021Open Access
197-LB: The Regulation of HSL by Macrophage Migration Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Obesity
Diabetes·2021· 2 cited
CD74 is a regulator of hematopoietic stem cell maintenance
PLoS Biology·2021· 33 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Christine N. Metz(23), Lin Leng(13), Jürgen Bernhagen(10), Robert A. Mitchell(9), Thierry Calandra(7), Andreas Meinhardt(6), Michael Bacher(5), Tina Peng(4), Elias Lolis(4), Hui Y. Lan(4), Wei Mu(4), David J. Nikolic‐Paterson(4), Melanie Merk(4), Yibang Chen(3), Kirk R. Manogue(3), Jason Chesney(3), Niansheng Yang(3), Robert C. Atkins(3), Yousef Al‐Abed(3), Courtney McDonald(3)